Biogen (BIIB) Income from Non-Controlling Interests (2009 - 2023)

Biogen's Income from Non-Controlling Interests history runs 13 years deep, the most recent figure standing at -$800000.0 for Q4 2023.

• In Q4 2023, Income from Non-Controlling Interests rose 11.11% year-over-year to -$800000.0; the TTM figure through Sep 2024 stood at -$800000.0 (down 366.67% YoY), while the FY2023 annual figure was $400000.0, up 100.47% from the prior year.
• Income from Non-Controlling Interests for Q4 2023 stood at -$800000.0, down from -$200000.0 in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $577.0 million in Q2 2021, with the low at -$388.7 million in Q4 2021.
• The 4-year median for Income from Non-Controlling Interests is -$300000.0 (2020), against an average of $9.2 million.
• Peak annual rise in Income from Non-Controlling Interests reached 795.96% in 2021, while the deepest fall reached 129466.67% in 2021.
• Biogen's Income from Non-Controlling Interests stood at -$300000.0 in 2020, then sank by 129466.67% to -$388.7 million in 2021, then jumped by 99.77% to -$900000.0 in 2022, then rose by 11.11% to -$800000.0 in 2023.
• Business Quant data shows BIIB's Income from Non-Controlling Interests at -$800000.0 in Q4 2023, -$200000.0 in Q3 2023, and $1.7 million in Q2 2023.